Sean Duffy reports 10b5-1 sales of OMDA shares

Morgan Stanley Smith Barney LLC reports 10b5-1 sales of OMDA common stock by Sean Duffy.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC reports 10b5-1 sales of OMDA common stock by Sean Duffy. The filing lists three sales: 01/12/2026 of 230,479 shares for $3,595,149.73, 01/13/2026 of 40,796 shares for $650,773.71, and 12/10/2025 of 9,266 shares for $142,378.58.

Insights

Securities Compliance Analyst

Routine Rule 144/10b5-1 sales by an insider were reported; amounts and dates are listed.

The filing documents three 10b5-1 dispositions by Sean Duffy, specifying share counts and gross proceeds for each trade. The record lists broker details and identifies the trades as 10b5-1 sales, indicating they were made under a prearranged plan.

These sales are standard insider dispositions under an established plan; cash-flow treatment shows proceeds to the selling holder. Timing and plan terms are not disclosed beyond the sale dates in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What 10b5-1 sales for OMDA are reported in this Form 144?

The Form 144 lists three 10b5-1 sales by Sean Duffy: 230,479 shares on 01/12/2026, 40,796 shares on 01/13/2026, and 9,266 shares on 12/10/2025, with gross proceeds shown for each trade.

How much gross proceeds were reported for the OMDA sales?

Gross proceeds reported are $3,595,149.73 for 01/12/2026, $650,773.71 for 01/13/2026, and $142,378.58 for 12/10/2025, as stated in the filing for each respective sale.

Who is the selling party named in the OMDA Form 144?

The selling party identified is Sean Duffy, with trades executed through Morgan Stanley Smith Barney LLC according to the filing. Sales are labeled as 10b5-1 plan transactions in the provided excerpt.

Do the reported trades indicate the company received proceeds?

The filing attributes the proceeds to the selling holder; it does not state proceeds to the issuer. The excerpt lists gross amounts per trade, implying the sales were dispositions by the insider rather than primary issuances.

Are the OMDA sales described as part of a prearranged plan?

Yes, each disposition is labeled as a 10b5-1 sale in the excerpt, indicating the trades were executed under a prearranged trading plan. The filing does not disclose the plan’s full terms or start date within the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002069522
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OMADA HEALTH INC
SEC File Number	001-42679
Address of Issuer	611 Gateway Blvd, Suite 120 South San Francisco CALIFORNIA 94080
Phone	888-987-8337
Name of Person for Whose Account the Securities are To Be Sold	SEAN DUFFY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4063	57085.15	58925439	03/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/05/2025	Restricted Stock Units	Issuer			4063	03/05/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	01/13/2026	40796	650773.71
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	01/12/2026	230479	3595149.73
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	12/10/2025	9266	142378.58

144: Remarks and Signature

Remarks
Date of Notice	03/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sean Duffy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)